טריפסל

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); FIMBRAE TUPES 2 + 3 (FIM); PERTACTIN; PERTUSSIS ACELLULAR; TETANUS TOXOID

Available from:

MEDICI MEDICAL LTD, ISRAEL

ATC code:

J07AJ52

Pharmaceutical form:

תרחיף להזרקה

Composition:

PERTUSSIS ACELLULAR 10 MCG / 0.5 ML; FILAMENTOUS HAEMAGGLUTININ (FHA) 5 MCG / 0.5 ML; FIMBRAE TUPES 2 + 3 (FIM) 5 MCG / 0.5 ML; PERTACTIN 3 MCG / 0.5 ML; DIPHTHERIA TOXOID 30 IU / 0.5 ML; TETANUS TOXOID 40 IU / 0.5 ML

Administration route:

תוך-שרירי

Prescription type:

מרשם נדרש

Manufactured by:

SANOFI PASTEUR LTD, CANADA

Therapeutic group:

PERTUSSIS, PURIFIED ANTIGEN, COMBINATIONS WITH TOXOIDS

Therapeutic area:

PERTUSSIS, PURIFIED ANTIGEN, COMBINATIONS WITH TOXOIDS

Therapeutic indications:

Is indicated for the primary immunization of infants at or above the age of 2 months and as a booster in children up to their 6th birthday against diphtheria, tetanus and pertussis.

Authorization date:

2010-11-30